ISRCTN38657696已完成未知
Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer (NSCLC): a randomised trial of chemotherapy versus symptomatic treatment only in patients not suitable for radical radiotherapy
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
1999 presumed results in https://www.ncbi.nlm.nih.gov/pubmed/10506617 (added 30/10/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 75 years or under
- •2. Histologically or cytologically proven non-small cell lung cancer, ie adeno-squamous or large cell carcinoma
- •3. Clinically or radiologically evaluable disease
- •4. Inoperable, but clinically limited stage disease
- •5. World Health Organisation (WHO) performance status of 0-2
- •6. No previous chemotherapy or radiotherapy
- •7. No cerebral metastases, spinal cord compression or symptomatic superior vena cava obstruction
- •8. Normal renal function
- •9. No other previous or concurrent malignancy, except cone biopsied carcinoma in-situ of the cervix and adequately treated basal cell carcinoma of the skin
- •10. No indication that protocol treatment would exacerbate a serious pre-existing medical condition
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer (NSCLC): A randomised trial of chemotherapy plus radiotherapy versus radiotherapy aloneung (non-small cell) cancerLung (non-small cell)CancerISRCTN56319613Cancer Research UK (CRUK) (UK)
已完成
不适用
Randomised trial of ifosfamide, carboplatin and etoposide with mid-cycle vincristine (VICE) versus standard practice chemotherapy in patients with limited small cell lung cancer (SCLC) and good performance statusSmall cell lung cancer (SCLC)CancerISRCTN47862456Medical Research Council (MRC) (UK)402
已完成
不适用
A randomised study of Mitomycin, Vinblastine and Platinum (cisplatin) (MVP) three versus six cycles in advanced Non-Small Cell Lung Cancer (NSCLC)ung (non-small cell) cancerLung (non-small cell) cancerCancerISRCTN57675565Cancer Research UK (CRUK) (UK)308
终止
2 期
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerPancreatic CancerNCT00967291IRCCS San Raffaele21
暂停
不适用
EXtended use of FOsfomycin for the treatment of CYstitis in primary careNL-OMON25501MC Utrecht777